Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DSM Acquires 19% Equity Interest in Andre Pectin - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

DSM Acquires 19% Equity Interest in Andre Pectin

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Royal DSM, Heerlen, Netherlands, the global Life Sciences and Materials Sciences company, has signed agreements to acquire a 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing ingredients. In addition, the parties have agreed that DSM has option rights to increase its stake in Andre Pectin to a majority stake at a later stage. The agreements are subject to customary approvals and certain closing conditions,including the approval of the selling party’s shareholders. Closing is expected in Q3 2013.
 
Andre Pectin, headquartered in Yantai (Shandong Province, China), was established in 2003 and is active in the manufacturing and sale of apple and citrus pectin, a key food ingredient providing texture, as well as pectin related health supplements. Andre Pectin realizes annual net sales of around €30 million.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics